首站-论文投稿智能助手
典型文献
Nanosized drug delivery systems modulate the immunosuppressive microenvironment to improve cancer immunotherapy
文献摘要:
Immunotherapy that activates immune systems for combating cancer has yielded considerable clinical benefits recently.However,the immunosuppressive tumor microenvironment(ITME)is a major hurdle to immunotherapy as it supports tumor to evade immune surveillance.Reversing ITME facilitates the recruitment and activation of antitumor immune cells,thereby promoting immunotherapy.Our group has developed various nanosized drug delivery systems(NDDSs)to modulate ITME with enhanced efficacy and safety.In the review we introduce the ITME-remodeling strategies for improving immunotherapy based on NDDSs including triggering tumor cells to undergo immunogenetic cell death(ICD),applying tumor vaccine,and directly regulating intratumoral immune components(immune cells or cytokines).In order to guide the design of NDDSs for amplified effects of antitumor immunotherapy,the contributions and future directions of this field are also discussed.
文献关键词:
作者姓名:
Wen-lu Yan;Tian-qun Lang;Wen-hui Yuan;Qi Yin;Ya-ping Li
作者机构:
State Key Laboratory of Drug Research&Center of Pharmaceutics,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,501 Haike Road,Shanghai 201203,China;School of Pharmacy,University of Chinese Academy of Sciences,Beijing 100049,China;Yantai Key Laboratory of Nanomedicine&Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China;Shandong Laboratory of Yantai Drug Discovery,Bohai Rim Advanced Research Institute for Drug Discovery,Yantai 264117,China;School of Pharmacy,Yantai University,Yantai 264005,China
引用格式:
[1]Wen-lu Yan;Tian-qun Lang;Wen-hui Yuan;Qi Yin;Ya-ping Li-.Nanosized drug delivery systems modulate the immunosuppressive microenvironment to improve cancer immunotherapy)[J].中国药理学报(英文版),2022(12):3045-3054
A类:
ITME,NDDSs,immunogenetic
B类:
Nanosized,drug,delivery,systems,modulate,immunosuppressive,microenvironment,improve,cancer,immunotherapy,Immunotherapy,that,activates,immune,combating,has,yielded,considerable,clinical,benefits,recently,However,major,hurdle,supports,evade,surveillance,Reversing,facilitates,recruitment,activation,antitumor,cells,thereby,promoting,Our,group,developed,various,nanosized,enhanced,efficacy,safety,In,review,introduce,remodeling,strategies,improving,including,triggering,undergo,death,ICD,applying,vaccine,directly,regulating,intratumoral,components,cytokines,order,guide,design,amplified,effects,contributions,future,directions,this,field,are,also,discussed
AB值:
0.57562
相似文献
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
Xianbin Ma;Shaochen Yang;Tian Zhang;Shuo Wang;Qichao Yang;Yao Xiao;Xiaoxiao Shi;Peng Xue;Yuejun Kang;Gang Liu;Zhi-Jun Sun;Zhigang Xu-Key Laboratory of Luminescence Analysis and Molecular Sensing(Southwest University),Ministry of Education,School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices,Southwest University,Chongqing 400715,China;The State Key Laboratory Breeding Base of Basic Science of Stomatology(Hubei-MOST) & Key Laboratory of Oral Biomedicine,Ministry of Education,School and Hospital of Stomatology,Wuhan University,Wuhan 430079,China;State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine,School of Public Health,Xiamen University,Xiamen 361102,China
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
Perfluorooctyl bromide nanoemulsions holding MnO2 nanoparticles with dual-modality imaging and glutathione depletion enhanced HIFU-eliciting tumor immunogenic cell death
Xinping Kuai;Yuefei Zhu;Zheng Yuan;Shengyu Wang;Lin Lin;Xiaodan Ye;Yiping Lu;Yu Luo;Zhiqing Pang;Daoying Geng;Bo Yin-Department of Radiology,Huashan Hospital,Fudan University,Shanghai 200040,China;School of Pharmacy,Fudan University,Key Laboratory of Smart Drug Delivery,Ministry of Education,Shanghai 201203,China;Department of Radiology,Shanghai First Maternity and Infant Hospital,Tongji University School of Medicine,Shanghai 201204,China;Department of Radiology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 201800,China;Department of Radiology,Shanghai Chest Hospital,Shanghai Jiao Tong University,Shanghai 200030,China;State Key Laboratory of High Performance Ceramics and Superfine Microstructure,School of Chemical Science and Engineering,Shanghai 200092,China
Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy
Zaigang Zhou;Jiashe Chen;Yu Liu;Chunjuan Zheng;Wenjuan Luo;Lele Chen;Shen Zhou;Zhiming Li;Jianliang Shen-State Key Laboratory of Ophthalmology,Optometry and Vision Science,School of Ophthalmology and Optometry,School of Biomedical Engineering,Wenzhou Medical University,Wenzhou 325027,China;Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325000,China;Department of the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China;School&Hospital of Stomatology,Wenzhou Medical University,Wenzhou 325027,China;Oujiang Laboratory(Zhejiang Lab for Regenerative Medicine,Vision and Brain Health),Wenzhou 325000,China
Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents
Chengliang Sun;Yao Cheng;Xiaojia Liu;Gefei Wang;Wenjian Min;Xiao Wang;Kai Yuan;Yi Hou;Jiaxing Li;Haolin Zhang;Haojie Dong;Liping Wang;Chenguang Lou;Yanze Sun;Xinmiao Yu;Hongbin Deng;Yibei Xiao;Peng Yang-State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization,China Pharmaceutical University,Nanjing 210009,China;Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China;Department of Pharmacology,School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China;Beijing Institute of Clinical Pharmacy,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China;Department of Physics,Chemistry and Pharmacy,University of Southern Denmark,Campusvej 55,5230 Odense,Denmark;Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100050,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。